Q4 2018 13F Holders as of 31 Dec 2018
-
Type / Class
-
Equity / Class A Common Stock
-
Shares outstanding
-
112M
-
Number of holders
-
179
-
Total 13F shares, excl. options
-
84.3M
-
Shares change
-
+860K
-
Total reported value, excl. options
-
$1.68B
-
Value change
-
-$4.94M
-
Put/Call ratio
-
0.31
-
Number of buys
-
104
-
Number of sells
-
-82
-
Price
-
$19.95
Significant Holders of Evolent Health, Inc. - Class A Common Stock (EVH) as of Q4 2018
223 filings reported holding EVH - Evolent Health, Inc. - Class A Common Stock as of Q4 2018.
Evolent Health, Inc. - Class A Common Stock (EVH) has 179 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 84.3M shares
of 112M outstanding shares and own 75.55% of the company stock.
Largest 10 shareholders include Capital Research Global Investors (7.64M shares), JPMORGAN CHASE & CO (7.12M shares), Vanguard Group Inc (5.97M shares), Bank of New York Mellon Corp (5.38M shares), BlackRock Inc. (4.67M shares), RIVERBRIDGE PARTNERS LLC (3.8M shares), DIMENSIONAL FUND ADVISORS LP (3.24M shares), WADDELL & REED FINANCIAL INC (2.6M shares), EAGLE ASSET MANAGEMENT INC (2.35M shares), and Standard Life Aberdeen plc (2.11M shares).
This table shows the top 179 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.